Generic Drug Approval Process and Accessibility
After the hearing adjourned, Dr. Woodcock spoke informally with reporters for several minutes.
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic dr… read more
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic drugs. She talked about progress being made on reducing the drug application backlog, and efforts to expedite new generic drugs to market.
After the hearing adjourned, Dr. Woodcock spoke informally with reporters for several minutes. close
People in this video
-
Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
Related Video
-
Generic Drug Marketplace
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also ad…
-
Food and Drug Administrator Confirmation Hearing
Dr. Scott Gottlieb testified at a confirmation hearing on his nomination to be commissioner of the Food and Drug Adminis…
-
Prescription Drug Costs
Representatives from prescription drug manufacturing, distribution, and retail industries testified at a hearing on the …
-
Health and Human Services Secretary Confirmation Hearing
The Senate Health, Education, Labor, and Pensions Committee held a hearing on President Trump’s nomination of former Eli…